Abstract

Neutrophil diapedesis is an immediate step following infections and injury and is driven by complex interactions between leukocytes and various components of the blood vessel wall. Here, we show that perivascular mast cells (MC) are key regulators of neutrophil behaviour within the sub-endothelial space of inflamed venules. Using confocal intravital microscopy, we observe directed abluminal neutrophil motility along pericyte processes towards perivascular MCs, a response that created neutrophil extravasation hotspots. Conversely, MC-deficiency and pharmacological or genetic blockade of IL-17A leads to impaired neutrophil sub-endothelial migration and breaching of the pericyte layer. Mechanistically, identifying MCs as a significant cellular source of IL-17A, we establish that MC-derived IL-17A regulates the enrichment of key effector molecules ICAM-1 and CXCL1 in nearby pericytes. Collectively, we identify a novel MC-IL-17A-pericyte axis as modulator of the final steps of neutrophil diapedesis, with potential translational implications for inflammatory disorders driven by increased neutrophil diapedesis.

The blood vessel wall is a complex multi-layered structure, yet upon injury or infection, neutrophil leukocytes are rapidly migrating from the blood stream to the affected tissues, by a process termed diapedesis. Authors here show that the final steps of diapedesis through the outer pericyte layer is regulated by perivascular mast cells via IL-17A production.

Details

Title
Neutrophil breaching of the blood vessel pericyte layer during diapedesis requires mast cell-derived IL-17A
Author
Joulia, Régis 1   VIAFID ORCID Logo  ; Guerrero-Fonseca, Idaira María 2   VIAFID ORCID Logo  ; Girbl, Tamara 3 ; Coates, Jonathon A. 4   VIAFID ORCID Logo  ; Stein, Monja 4 ; Vázquez-Martínez, Laura 4 ; Lynam, Eleanor 4 ; Whiteford, James 4   VIAFID ORCID Logo  ; Schnoor, Michael 5   VIAFID ORCID Logo  ; Voehringer, David 6   VIAFID ORCID Logo  ; Roers, Axel 7   VIAFID ORCID Logo  ; Nourshargh, Sussan 8 ; Voisin, Mathieu-Benoit 8   VIAFID ORCID Logo 

 Queen Mary University of London, Charterhouse Square, William Harvey Research Institute, Faculty of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133); NHLI, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 Queen Mary University of London, Charterhouse Square, William Harvey Research Institute, Faculty of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133); CINVESTAV-IPN, Department of Molecular Biomedicine, Mexico City, Mexico (GRID:grid.512574.0) 
 Queen Mary University of London, Charterhouse Square, William Harvey Research Institute, Faculty of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133); University of Würzburg, Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658) 
 Queen Mary University of London, Charterhouse Square, William Harvey Research Institute, Faculty of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133) 
 CINVESTAV-IPN, Department of Molecular Biomedicine, Mexico City, Mexico (GRID:grid.512574.0) 
 University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Department of Infection Biology, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525) 
 Heidelberg University Hospital, Institute for Immunology, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908) 
 Queen Mary University of London, Charterhouse Square, William Harvey Research Institute, Faculty of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133); Queen Mary University of London, Centre for Inflammation and Therapeutic Innovation, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2737279122
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.